Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 10801–10820 of 17,529 recalls

October 28, 2016· Nationwide Laboratories, LLC

Recalled Item: Phenazopyridine Hydrochloride Tablets

The Issue: CGMP Deviations: manufactured under practices which may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 28, 2016· Nationwide Laboratories, LLC

Recalled Item: Salsalate Tablets

The Issue: CGMP Deviations: manufactured under practices which may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 28, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: KENALOG (Triamcinolone Acetonide) Spray with Spray Tube Topical Aerosol

The Issue: Failed Stability Specifications: Low Out of Specification results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 27, 2016· Amerisource Health Services

Recalled Item: Bupropion Hydrochloride Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: UROPHEN MB URINARY ANTISEPTIC Tablets

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: UROLET MB URINARY ANTISEPTIC

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: Phenazopyridine Hydrochloride Tablets

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: AZUPHEN MB URINARY ANTISEPTIC Capsules

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: Phenazopyridine Hydrochloride Tablets

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: URAMIT MB URINARY ANTISEPTIC Capsules

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: Hyolev MB URINARY ANTISEPTIC Tablets

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2016· Burel Pharmaceuticals Inc

Recalled Item: Indiomin MB URINARY ANTISEPTIC

The Issue: CGMP Deviations; deficiencies at the manufacturer may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 21, 2016· Akorn Inc

Recalled Item: Sodium Chloride Ophthalmic Solution

The Issue: Subpotent Drug: concentration of product is less than

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 20, 2016· CutisPharma, Inc.

Recalled Item: FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit

The Issue: Labeling: Label error on declared strength. Package Insert

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 20, 2016· CutisPharma, Inc.

Recalled Item: FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit

The Issue: Labeling: Label error on declared strength. Package Insert

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 19, 2016· Inventia Healthcare Private Limited

Recalled Item: Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 19, 2016· Sandoz Inc

Recalled Item: Ceftriaxone for Injection

The Issue: Labeling: Missing Label

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 19, 2016· Janssen Ortho L.L.C.

Recalled Item: Invokamet (canagliflozin and metformin HCl) tablets

The Issue: Labeling: Incorrect or Missing Package Insert - Xarelto

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 18, 2016· Town and Country Compounding and Consultation Services, LLC

Recalled Item: HCG (Chorionic Gonadotropin Lyopholized) II

The Issue: Subpotent Drug: due to failed potency results of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 18, 2016· GSK Consumer Healthcare

Recalled Item: Zeasorb AF (miconazole nitrate)

The Issue: Labeling Not Elsewhere Classified: front labels have the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund